Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-09-19 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TREMBLAY-EN-FRANCE (93290), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE DU VERT GALANT : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE DU VERT GALANT is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TREMBLAY-EN-FRANCE (93290),
this company of category PME
shows in 2022 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE DU VERT GALANT (SIREN 832085450)
Indicator
2023
2022
2021
2020
2018
Revenue
N/C
2 850 662 €
N/C
N/C
N/C
Net income
124 832 €
130 930 €
332 563 €
155 341 €
118 811 €
EBITDA
N/C
329 034 €
N/C
N/C
N/C
Net margin
N/C
4.6%
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE CENTRALE DU VERT GALANT generates positive net income of 125 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2023: 119 k€ -> 125 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
124 832 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 148%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
148.328%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
34.45%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE DU VERT GALANT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2020
2021
2022
2023
Debt ratio
1645.01
446.922
223.333
208.364
148.328
Financial autonomy
5.013
15.888
26.714
27.629
34.45
Repayment capacity
None
None
None
10.171
None
Cash flow / Revenue
None%
None%
None%
5.098%
None%
Sector positioning
Debt ratio
148.332023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-5 pts over 3 years
In 2023, the debt ratio of PHARMACIE CENTRALE DU VER... (148.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
34.45%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+6 pts over 3 years
In 2023, the financial autonomy of PHARMACIE CENTRALE DU VER... (34.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
10.17 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE CENTRALE DU VER... (10.17) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 130.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
130.275
Liquidity indicators evolution PHARMACIE CENTRALE DU VERT GALANT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2020
2021
2022
2023
Liquidity ratio
163.449
139.925
163.57
155.59
130.275
Interest coverage
None
None
None
3.062
None
Sector positioning
Liquidity ratio
130.282023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch-13 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE CENTRALE DU VER... (130.28) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
3.06x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE CENTRALE DU VER... (3.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CENTRALE DU VERT GALANT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
202 426 €
0 €
Inventory turnover (days)
0
0
0
31
0
Customer payment term (days)
0
68
187
4
0
Supplier payment term (days)
0
900
907
46
0
Positioning of PHARMACIE CENTRALE DU VERT GALANT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE CENTRALE DU VERT GALANT is estimated at
1 472 952 €
(range 895 772€ - 2 070 640€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
895k€1472k€2070k€
1 472 952 €Range: 895 772€ - 2 070 640€
NAF 5 année 2023
Valuation method used
Net Income Multiple
124 832 €
×
11.8x
=1 472 952 €
Range: 895 773€ - 2 070 640€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE DU VERT GALANT with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE DU VERT GALANT
What is the revenue of PHARMACIE CENTRALE DU VERT GALANT ?
The revenue of PHARMACIE CENTRALE DU VERT GALANT in 2022 is 2.9 M€.
Is PHARMACIE CENTRALE DU VERT GALANT profitable?
Yes, PHARMACIE CENTRALE DU VERT GALANT generated a net profit of 125 k€ in 2023.
Where is the headquarters of PHARMACIE CENTRALE DU VERT GALANT ?
The headquarters of PHARMACIE CENTRALE DU VERT GALANT is located in TREMBLAY-EN-FRANCE (93290), in the department Seine-Saint-Denis.
Where to find the tax return of PHARMACIE CENTRALE DU VERT GALANT ?
The tax return of PHARMACIE CENTRALE DU VERT GALANT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE DU VERT GALANT operate?
PHARMACIE CENTRALE DU VERT GALANT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart